Researchers at Jerusalem’s Shaare Zedek Medical Center have concluded that all Jewish women of Ashkenazi origin should be screened for BRCA1 or BRCA2 genetic mutations from age 30. 40% of ovarian cancer cases in Ashkenazi Jews are due to these mutations.
Genetic screening can save women from cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.